Additionally, ALKBH5 can act as a tumor suppressor to impede NSCLC progression by downregulating YTHDF1/2/3-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity (84). The gene discussed is YTHDF1; the disease is neoplasm.